Amgen (AMGN) Tops Q2 EPS by 29c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Amgen (AMGN) PT Raised to $179 at Baird
July 27, 2018 8:48 AM EDTBaird raised its price target on Amgen (NASDAQ: AMGN) to $179.00 (from $165.00) while maintaining a Neutral rating.
... MoreAmgen (AMGN) PT Raised to $205 at Cowen Following 'Beat and Raise'
July 27, 2018 8:24 AM EDTCowen raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $204.00) while maintaining a Outperform rating.
Analyst Phil Nadeau commented, "Amgen reported Q2 revenue of $6.06B (+4% Y/Y, vs. consensus of $5.73BE) and non-GAAP EPS of $3.83 (+17% Y/Y, vs. consensus of $3.54E). Amgen both... More
Amgen (AMGN) PT Raised to $194 at UBS
July 27, 2018 7:00 AM EDTUBS raised its price target on Amgen (NASDAQ: AMGN) to $194.00 (from $180.00) while maintaining a Neutral rating.
... MoreAmgen (AMGN) PT Raised to $195 at Barclays
July 27, 2018 6:56 AM EDTBarclays raised its price target on Amgen (NASDAQ: AMGN) to $195.00 (from $180.00) while maintaining a Equalweight rating following the company's 2Q earnings report.
Amgens portfolio looks poised to deliver flat growth in 2018e, which, in Barclays view, will likely keep... More
Amgen (AMGN) PT Raised to $210 at Piper Jaffray Following 2Q
July 27, 2018 6:45 AM EDTPiper Jaffray raised its price target on Amgen (NASDAQ: AMGN) to $210.00 (from $190.00) while maintaining a Overweight rating following the company's 2Q earnings report. AMGN posted Q218 non-GAAP EPS of $3.83, well ahead of consensus $3.55. Upside was operationally driven as revenue beat handily (total revenue was... More
